BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38536200)

  • 1. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
    Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
    Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
    Del Principe MI; Buccisano F; Soddu S; Maurillo L; Cefalo M; Piciocchi A; Consalvo MI; Paterno G; Sarlo C; De Bellis E; Zizzari A; De Angelis G; Fraboni D; Divona M; Voso MT; Sconocchia G; Del Poeta G; Lo-Coco F; Arcese W; Amadori S; Venditti A
    Semin Hematol; 2018 Oct; 55(4):209-214. PubMed ID: 30502849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion and Pattern of Central Nervous System Involvement in Acute Leukemia on Diagnosis.
    Yeasmin S; Rashid MH; Debnath MR; Rashid MM
    Mymensingh Med J; 2022 Jan; 31(1):55-60. PubMed ID: 34999680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleukemia in adults].
    Beslać-Bumbasirević Lj; Bosković D; Tomin D; Colović M; Kovacević M; Bumbasirević V
    Srp Arh Celok Lek; 1996; 124(3-4):82-6. PubMed ID: 9102825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.
    Prem S; Atenafu EG; Avena J; Bautista R; Law A; Lam W; Michelis FV; Kim DDH; Viswabandya A; Lipton JH; Mattsson J; Kumar R
    Eur J Haematol; 2019 Nov; 103(5):483-490. PubMed ID: 31418930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia.
    Popov A; Henze G; Verzhbitskaya T; Roumiantseva J; Lagoyko S; Khlebnikova O; Streneva O; Bidanov O; Tsaur G; Inaba H; Karachunskiy A; Fechina L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1331-1339. PubMed ID: 30840196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
    Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia.
    Gu J; Huang X; Zhang Y; Bao C; Zhou Z; Tong H; Jin J
    Front Oncol; 2022; 12():1013781. PubMed ID: 36531024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
    Alakel N; Stölzel F; Mohr B; Kramer M; Oelschlägel U; Röllig C; Bornhäuser M; Ehninger G; Schaich M
    Cancer Manag Res; 2017; 9():97-102. PubMed ID: 28435324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
    Rozovski U; Ohanian M; Ravandi F; Garcia-Manero G; Faderl S; Pierce S; Cortes J; Estrov Z
    Leuk Lymphoma; 2015 May; 56(5):1392-7. PubMed ID: 25110819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation.
    Bar M; Tong W; Othus M; Loeb KR; Estey EH
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):546-51. PubMed ID: 25545726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system involvement in patients with acute myeloid leukemia.
    Yaşar HA; Çınar OE; Köylü NY; Barışta İ; Göker H; Büyükaşık Y
    Turk J Med Sci; 2021 Oct; 51(5):2351-2356. PubMed ID: 33932973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
    Goulart H; Sastow D; Moshier E; Martin L; Mascarenhas J; Tremblay D
    Leuk Res; 2024 Feb; 137():107452. PubMed ID: 38335816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement.
    Sastow D; Tatarian J; Riazat-Kesh YJRA; Farina K; Becker M; Feld J; Kremyanskaya M; Mascarenhas J; Byrd K; Male HJ; Lin TL; Tremblay D
    Leuk Lymphoma; 2023 Dec; 64(12):2002-2007. PubMed ID: 37590099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A narrative review of central nervous system involvement in acute leukemias.
    Deak D; Gorcea-Andronic N; Sas V; Teodorescu P; Constantinescu C; Iluta S; Pasca S; Hotea I; Turcas C; Moisoiu V; Zimta AA; Galdean S; Steinheber J; Rus I; Rauch S; Richlitzki C; Munteanu R; Jurj A; Petrushev B; Selicean C; Marian M; Soritau O; Andries A; Roman A; Dima D; Tanase A; Sigurjonsson O; Tomuleasa C
    Ann Transl Med; 2021 Jan; 9(1):68. PubMed ID: 33553361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia.
    Thastrup M; Marquart HV; Schmiegelow K
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
    Cheng CL; Li CC; Hou HA; Fang WQ; Chang CH; Lin CT; Tang JL; Chou WC; Chen CY; Yao M; Huang SY; Ko BS; Wu SJ; Tsay W; Tien HF
    BMC Cancer; 2015 May; 15():344. PubMed ID: 25934556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.